Small Molecule Drug Discovery - Global Strategic Business Report Forecasts Growth from $61.5B (2024) to $100B by 2030, Profiling AstraZeneca, Gilead Sciences, Merck & Pfizer1 report from 1 outlet in 1 language · first reported 2026-09-29 09:22 UTC · updated 2026-09-29 09:22 UTC · JSONEconomy & businessAstraZenecaGilead SciencesMerckPfizerReportsSmall Molecule Drug Discovery - Global Strategic Business Report Forecasts Growth from $61.5B (2024) to $100B by 2030, Profiling AstraZeneca, Gilead Sciences, Merck & PfizerGlobeNewswire — all · en · 2026-09-29 09:22 UTC